It is provided for scientific reference and does not constitute a recommendation for individual use, medical advice, or application instructions
The approval was based on data from the Phase III KarMMa-3 trial, where treatment with Abecma tripled the progression-free survival rate
Other: Li-Juan Nie, Jun Liang, Feng Shan, Bao-Shi Wang, Yuan-Yuan Mu, Xie-Hai Zhou, Qing-Rong Xia (2021 Sep) L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder
However, the metabolic enhancement 5-amino-1mq provides may make a given caloric deficit more effective, meaning faster results without more extreme restriction
OCTN: a small transporter subfamily with great relevance to human pathophysiology, drug discovery, and diagnostics